Volume 68, Issue 1 pp. 8-13
Human Cancer

Body-size indicators and risk of breast cancer according to menopause and estrogen-receptor status

Satu Männistö

Corresponding Author

Satu Männistö

Department of Nutrition, National Public Health Institute, Helsinki, Finland

Department of Nutrition, National Public Health Institute, Mannerheimintie 166, 00300 Helsinki, Finland. Fax: 358 g 4744591Search for more papers by this author
Pirjo Pietinen

Pirjo Pietinen

Department of Nutrition, National Public Health Institute, Helsinki, Finland

Search for more papers by this author
Marjo Pyy

Marjo Pyy

Department of Nutrition, National Public Health Institute, Helsinki, Finland

Search for more papers by this author
Juni Palmgren

Juni Palmgren

Department of Nutrition, National Public Health Institute, Helsinki, Finland

Search for more papers by this author
Matti Eskelinen

Matti Eskelinen

Department of Surgery, Kuopio University Hospital, Kuopio, Finland

Search for more papers by this author
Matti Uusitupa

Matti Uusitupa

Department of Clinical Nutrition, Kuopio University, Kuopio, Finland

Search for more papers by this author

Abstract

Associations between the risk of breast cancer and body-size indicators at the time of breast-cancer diagnosis were assessed among 328 pre-menopausal or post-menopausal cases and 417 controls participating in the Kuopio Breast Cancer Study. This case-control study follows the protocol of the international Collaborative Study of Breast and Colorectal Cancer. When the potential confounding factors were taken into account, tallness was related to increased risk of breast cancer, especially in post-menopausal women, whereas no clear association with body-mass index (BMI) was found. Waist-to-hip ratio (WHR) was the most important risk factor in both pre-menopausal and post-menopausal women. The post-menopausal cases with high positive estrogen-receptor status (ER++) had the highest weight and BMI; they had also the biggest weight gain since the age of 20. However, the association between WHR and breast cancer appeared to be independent of estrogen-receptor status. Our results suggest that WHR may be a better marker for breast cancer than the degree of adiposity. © 1996 Wiley-Liss, Inc.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.